CV6 Therapeutics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3.39M
- Investors
-
6
CV6 Therapeutics General Information
Description
Operator of a drug development company intended to treat human diseases and cancer. The company analyzes cancer cells for the identification of new drug targets that exploit key vulnerabilities in cancer cells and to overcome the problem of chemotherapy resistance, enabling researchers and medical professionals to develop therapeutics and improve the lives of patients with cancer and inflammatory diseases.
Contact Information
Website
www.cv6t.comCorporate Office
- Health Sciences Building, Centre for Cancer Research & Cell Biology
- 97 Lisburn Road
- Belfast BT9 7AE
- Northern Ireland, United Kingdom
Corporate Office
- Health Sciences Building, Centre for Cancer Research & Cell Biology
- 97 Lisburn Road
- Belfast BT9 7AE
- Northern Ireland, United Kingdom
CV6 Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 02-Nov-2022 | $3.39M | Completed | Clinical Trials - General | ||
| 3. Later Stage VC | 02-Nov-2022 | Completed | Clinical Trials - General | |||
| 2. Later Stage VC | 03-Mar-2021 | Completed | Clinical Trials - General | |||
| 1. Early Stage VC | 24-May-2016 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CV6 Therapeutics Comparisons
Industry
Financing
Details
CV6 Therapeutics Competitors (59)
One of CV6 Therapeutics’s 59 competitors is HemoShear Therapeutics, a Venture Capital-Backed company based in Charlottesville, VA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| HemoShear Therapeutics | Venture Capital-Backed | Charlottesville, VA | ||||
| viDA Therapeutics | Venture Capital-Backed | Vancouver, Canada | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA | ||||
| Aculys | Formerly VC-backed | Tokyo, Japan | ||||
| Regenerx | Formerly VC-backed | Rockville, MD |
CV6 Therapeutics Patents
CV6 Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026156174-A1 | Parp inhibitor combination therapy with deoxyuridine triphosphatase inhibitors | Pending | 16-Jan-2025 | ||
| AU-2021297566-A1 | Combination therapy with deoxyuridine triphosphatase inhibitors | Pending | 26-Jun-2020 | ||
| CA-3185648-A1 | Combination therapy with deoxyuridine triphosphatase inhibitors | Pending | 26-Jun-2020 | ||
| EP-4171549-A1 | Combination therapy with deoxyuridine triphosphatase inhibitors | Active | 26-Jun-2020 | ||
| EP-4171549-B1 | Combination therapy with deoxyuridine triphosphatase inhibitors | Active | 26-Jun-2020 | A61K31/4166 |
CV6 Therapeutics Signals
CV6 Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Clarendon Fund Managers | Venture Capital | Minority | ||
| Techstart Ventures | Venture Capital | Minority | ||
| European Regional Development Fund (Brandenburg) | Government | Minority | ||
| Forepont Capital Partners | Venture Capital | Minority | ||
| Invest Northern Ireland | Limited Partner | Minority |
CV6 Therapeutics FAQs
-
When was CV6 Therapeutics founded?
CV6 Therapeutics was founded in 2013.
-
Where is CV6 Therapeutics headquartered?
CV6 Therapeutics is headquartered in Belfast, United Kingdom.
-
What is the size of CV6 Therapeutics?
CV6 Therapeutics has 10 total employees.
-
What industry is CV6 Therapeutics in?
CV6 Therapeutics’s primary industry is Drug Discovery.
-
Is CV6 Therapeutics a private or public company?
CV6 Therapeutics is a Private company.
-
What is CV6 Therapeutics’s current revenue?
The current revenue for CV6 Therapeutics is .
-
How much funding has CV6 Therapeutics raised over time?
CV6 Therapeutics has raised $5.66M.
-
Who are CV6 Therapeutics’s investors?
Clarendon Fund Managers, Techstart Ventures, European Regional Development Fund (Brandenburg), Forepont Capital Partners, and Invest Northern Ireland are 5 of 6 investors who have invested in CV6 Therapeutics.
-
Who are CV6 Therapeutics’s competitors?
HemoShear Therapeutics, viDA Therapeutics, NGM Biopharmaceuticals, Aculys, and Regenerx are some of the 59 competitors of CV6 Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process